FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Valeant Pharmaceuticals North America Cortaid 12-Hour Advanced Anti-itch Cream Recall

Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone)

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Oct 31, 2018
Recall ID
D-0086-2019
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Cortaid 12-Hour Advanced Anti-itch Cream starting Aug 24, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0086-2019 on Oct 31, 2018. Reason: CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident. Status: Terminated.

Why it was recalled

CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.

Product description

Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. (42 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875519155

Lot numbers, UPCs & expiration codes

Lot #: 172185F, Exp 6/19

Where it was sold

Product was distributed throughout the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0086-2019
Classification
Class II
Status
Terminated
Recall initiated
Aug 24, 2018
FDA report date
Oct 31, 2018
Quantity
5,016 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0086-2019, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
81004
Address
400 Somerset Corporate Blvd
Code information
Lot #: 172185F, Exp 6/19
Postal code
08807-2867
Report date
Oct 31, 2018
Product type
Drugs
Recall number
D-0086-2019
Classification
Class II
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
5,016 tubes
Termination date
Mar 6, 2020
Reason for recall
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. (42 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875519155
Distribution pattern
Product was distributed throughout the United States
Recall initiation date
Aug 24, 2018
Initial firm notification
Letter
Center classification date
Oct 22, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0086-2019, published Oct 31, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls